In this issue:
Mesalazine not effective in recurrent diverticulitis
Discrimination in biologic therapy access in CD patients
Mucosal dysbiosis in siblings of CD patients
CD management after intestinal resection
Faecal calprotectin and CD recurrence after surgery
Travel health and pre-travel preparation in IBD patients
Predicting the high-risk IBD patient
Optimising biological therapy in IBD patients
Vaccinations in adult IBD patients
IVF in women with IBD
Personal viewpoint: Treating to Target in IBD
Please login below to download this issue (PDF)